A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer.
A phase III double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
A prospective observational study of artificial intelligence based radiotherapy treatment planning for cervical, head and neck and prostate cancer
Duration of androgen suppression with post-operative radiotherapy (DADSPORT): A meta-analysis of aggregate data
STOPCAP M1 Programme
Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer